Ep. 344 - JPM Momentum and Asia’s Hotbeds of Innovation

The J.P. Morgan Healthcare Conference kicked off this week with sunny skies over San Francisco and more financial momentum than the biotech industry has seen in years. On a special “on the road” edition of the BioCentury This Week podcast, recorded on the sidelines of the annual JPM conference, special guests joined BioCentury’s analysts to discuss the biotech ecosystems in Asia. The wide-ranging conversation spans dealmaking, including the pricing dynamics of assets in China and RNAi’s prospects of becoming the region’s next hot modality; plus the state of the capital markets, the global implications of “China speed” in the clinic, and what’s changing for start-ups in Japan. Joining BioCentury were Panacea Venture’s James Huang, MayTech Global Investments’ Ingrid Yin, DLA Piper’s Ting Xiao and CBRE’s Matt Gardner. The podcast was recorded at the 12th East-West Healthcare Reception, hosted by BioCentury, MayTech Global and Panacea. View full story: 00:00 - Introduction 02:02 - Split Screen 2026 05:57 - China's Rapid Progress 08:01 - AI and Biotech 16:58 - Deal Prices 22:56 - Public Markets 28:47 - Innovation Across Asia To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com. Reach us by sending a text

You can listen to Ep. 344 - JPM Momentum and Asia’s Hotbeds of Innovation online on Radio and Podcast. Open the player on this page to stream the available audio.

Ep. 344 - JPM Momentum and Asia’s Hotbeds of Innovation is an episode from BioCentury This Week by BioCentury.

This episode is 43:19 long.

This episode was published on Jan 15, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from BioCentury This Week when more episodes are available from the podcast feed.